Immuneering Corp financial data

Symbol
IMRX on Nasdaq
Location
245 Main Street, Second Floor, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.29K % -21.9%
Debt-to-equity 12.3 % +24.7%
Return On Equity -66 % -41.5%
Return On Assets -58.8 % -38.4%
Operating Margin -12.3M % -127560%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 239M USD +113%
Weighted Average Number of Shares Outstanding, Basic 29.7M shares +3.51%
Weighted Average Number of Shares Outstanding, Diluted 29.7M shares +3.51%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Cost of Revenue 0 USD -100%
Research and Development Expense 43.8M USD +12.7%
General and Administrative Expense 16.6M USD +1.02%
Operating Income (Loss) -60.5M USD -9.23%
Net Income (Loss) Attributable to Parent -56.1M USD -8.06%
Earnings Per Share, Basic -1.9 USD/shares +1.04%
Earnings Per Share, Diluted -1.9 USD/shares +1.04%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 59.7M USD -42.6%
Marketable Securities, Current 32.9M USD -55.7%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 63.7M USD -42.9%
Property, Plant and Equipment, Net 1.29M USD -5.54%
Operating Lease, Right-of-Use Asset 3.83M USD -8.73%
Goodwill 6.69M USD 0%
Other Assets, Noncurrent 1.23M USD +65.1%
Assets 77.1M USD -38.3%
Accounts Payable, Current 2.62M USD -2.63%
Accrued Liabilities, Current 3.76M USD +54.8%
Liabilities, Current 6.78M USD +23.8%
Operating Lease, Liability, Noncurrent 4M USD -7.22%
Other Liabilities, Noncurrent 9.9K USD
Liabilities 10.8M USD +10.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -192M USD -41.4%
Stockholders' Equity Attributable to Parent 66.3M USD -42.4%
Liabilities and Equity 77.1M USD -38.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.5M USD -7.44%
Net Cash Provided by (Used in) Financing Activities 980K USD +309%
Net Cash Provided by (Used in) Investing Activities 21.4M USD +12.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.88M USD +43.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 59.7M USD -42.6%
Deferred Tax Assets, Valuation Allowance 43.3M USD +35.1%
Deferred Tax Assets, Gross 43.7M USD +33%
Operating Lease, Liability 4.31M USD -7.16%
Depreciation 90.2K USD +17.9%
Payments to Acquire Property, Plant, and Equipment 37.5K USD +33.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -56.1M USD -8.43%
Lessee, Operating Lease, Liability, to be Paid 6.33M USD -11%
Property, Plant and Equipment, Gross 2.2M USD +13.6%
Operating Lease, Liability, Current 311K USD -6.38%
Lessee, Operating Lease, Liability, to be Paid, Year Two 762K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 740K USD +0.98%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +11%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.02M USD -18.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 785K USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 19.1M USD -8.38%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 700K USD +29.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 808K USD +3%
Operating Lease, Payments 193K USD -11.1%
Additional Paid in Capital 258M USD +2.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 29.3K USD 0%
Depreciation, Depletion and Amortization 90.5K USD +15.7%
Deferred Tax Assets, Net of Valuation Allowance 390K USD -49.9%
Share-based Payment Arrangement, Expense 5.19M USD +10%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%